The Functional Genomics Group at the Peter MacCallum Cancer Centre encompasses siRNA and shRNA whole genome screening platforms. The Facility is accessible to researchers Australia-wide and offers the human and mouse whole genome siRNA reagents and the lentiviral based pGIPZ human shRNA-mir collection as complex pools of 4608 constructs for whole genome screening or as boutique pools for specific library collections (e.g apoptosis, cell cycle).

The Peter MacCallum Cancer Centre houses the largest cancer research group in Australia, with over 400 staff across the Centre involved in cancer research. The combination of a specialist cancer hospital and an embedded sophisticated laboratory complex provides unparalleled opportunities to inform clinical practice and engage in translational clinical research. The spectrum of research ranges from laboratory-based studies into the fundamental mechanisms of cell growth, translational studies that seek more accurate cancer diagnosis, clinical trials with novel treatments, to research aimed at improving our supportive care of patients.

For more information please visit our website at
http://www.petermac-research.org.